Veru, Inc. (VERU)
2.63
-0.02
(-0.75%)
USD |
NASDAQ |
Dec 09, 16:00
2.60
-0.03
(-1.14%)
After-Hours: 20:00
Veru Cash from Financing (Quarterly): 0.00 for June 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Onconetix, Inc. | 4.291M |
| CEL-SCI Corp. | 3.808M |
| AIM ImmunoTech, Inc. | 6.654M |
| IGC Pharma, Inc. | 3.11M |
| NovaBay Pharmaceuticals, Inc. | -1.319M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.482M |
| Cash from Investing (Quarterly) | 0.4741M |
| Free Cash Flow | -28.98M |
| Free Cash Flow Per Share (Quarterly) | -0.374 |
| Free Cash Flow to Equity (Quarterly) | -5.348M |
| Free Cash Flow to Firm (Quarterly) | -5.482M |
| Free Cash Flow Yield | -9.71% |